154 related articles for article (PubMed ID: 37259800)
21. THE ADDED VALUE OF BLOOD GLUCOSE MONITORING IN HIGH-RISK INDIVIDUALS UNDERGOING PANCREATIC CANCER SURVEILLANCE.
Bogdanski AM; Onnekink AM; Inderson A; Boekestijn B; Bonsing BA; Vasen HFA; van Hooft JE; Boonstra JJ; Mieog JSD; Wasser MNJM; Feshtali S; Potjer TP; Klatte DCF; van Leerdam ME
Pancreas; 2024 Apr; ():. PubMed ID: 38598368
[TBL] [Abstract][Full Text] [Related]
22. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
23. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract][Full Text] [Related]
25. Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma.
Thiruvengadam SS; Chuang J; Huang R; Girotra M; Park WG
Gastrointest Endosc; 2019 Apr; 89(4):842-851.e1. PubMed ID: 30145314
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract][Full Text] [Related]
27. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
28. An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
Rainone M; Singh I; Salo-Mullen EE; Stadler ZK; O'Reilly EM
JAMA Oncol; 2020 May; 6(5):764-771. PubMed ID: 32053139
[TBL] [Abstract][Full Text] [Related]
29. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
Klatte DCF; Boekestijn B; Onnekink AM; Dekker FW; van der Geest LG; Wasser MNJM; Feshtali S; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME;
Gastroenterology; 2023 Jun; 164(7):1223-1231.e4. PubMed ID: 36889551
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic Cysts Greater Than 1 cm Are Associated With an Increased Risk for Developing Pancreatic Cancer in Individuals From Pancreatic-Cancer Prone Kindreds Undergoing Surveillance.
Aijazi M; Fasanella KE; McGrath K; Smith LM; Singhi AD; Brand RE
Pancreas; 2024 Apr; 53(4):e350-e356. PubMed ID: 38518061
[TBL] [Abstract][Full Text] [Related]
32. Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer.
Majumder S; Taylor WR; Foote PH; Gysbers BJ; Cao X; Mahoney DW; Burger KN; Doering KA; Graham RP; Couch FJ; Petersen GM; Kisiel JB
Pancreatology; 2022 Sep; 22(6):770-773. PubMed ID: 35843766
[TBL] [Abstract][Full Text] [Related]
33. Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma.
Nguyen D; Gilad O; Drogan CM; Eilers Z; Liao C; Kupfer SS
J Med Genet; 2024 Feb; 61(3):270-275. PubMed ID: 37852748
[TBL] [Abstract][Full Text] [Related]
34. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
35. Multicenter study of early pancreatic cancer in Japan.
Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
[TBL] [Abstract][Full Text] [Related]
36. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
[TBL] [Abstract][Full Text] [Related]
38. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
